Related Experiment Video
Updated: Jul 8, 2026

Description of a Swine Infant Model of Volume-Controlled Hemorrhagic Shock
Published on: November 3, 2023
Coagulation testing in pediatric patients: the young are not just miniature adults
Giuseppe Lippi1, Massimo Franchini, Martina Montagnana
1Dipartimento di Scienze Biomediche e Morfologiche, Università di Verona, Verona, Italy. giuseppe.lippi@univr.it
Insights
Pediatric hemostasis differs from adults, with unique protective mechanisms. Accurate interpretation of coagulation tests in children requires age-specific reference ranges to avoid misdiagnosis of bleeding or clotting disorders.
Area of Science:
- Pediatric Hematology
- Hemostasis and Thrombosis
- Coagulation Physiology
Background:
- Significant advancements have been made in understanding the development of the hemostatic system.
- The physiology of hemostasis in pediatric patients shows considerable differences compared to adults.
- These variations suggest potential natural protective mechanisms in children.
Purpose of the Study:
- To emphasize the importance of understanding normal postnatal development of the human coagulation system.
- To highlight the necessity of correct interpretation of hemostasis test results in pediatric patients.
- To underscore the prerequisites for investigating thrombotic and hemorrhagic issues in children.
Main Methods:
- Review of current literature on pediatric hemostasis and coagulation development.
- Analysis of physiological differences between adult and pediatric hemostatic systems.
- Emphasis on the role of age-dependent reference ranges in laboratory data interpretation.
Main Results:
- The hemostatic system in children is not fully mature until 3 to 6 months of age.
- Pediatric hemostasis exhibits distinct physiological characteristics compared to adults.
- Misclassification of coagulation defects can occur without appropriate age-specific reference ranges.
Conclusions:
- Accurate interpretation of pediatric hemostasis tests is crucial for diagnosing bleeding and clotting disorders.
- Age-dependent and testing system-specific reference ranges are essential for pediatric laboratory data.
- Understanding the developing coagulation system in children prevents misdiagnosis of factor deficiencies and inhibitors.
Abstract:
During the past few decades, great progress has been made toward a better understanding of the development of the hemostatic system. It is now clear that the physiology of hemostasis in pediatric patients differs widely from that in adults, supporting the hypothesis that children might have natural protective mechanisms that justify such variations. However, the correct interpretation of hemostasis test results in young patients, along with a deep understanding of the normal postnatal development in the human coagulation system, are essential prerequisites to the proper investigation of thrombotic and hemorrhagic problems in pediatric patients. Because the hemostatic system is not fully mature by 3 to 6 months of age, it is important to recognize that interpretation of laboratory data in pediatric patients must be accompanied by appropriate age-dependent reference ranges, which should also be specific for the testing system used, to prevent misclassification of children as having defects of factors and inhibitors of the coagulation system.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Drug Dosing: Infants and Children
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Coagulation

